View in EDS

PET-based risk stratification for adverse events under [225Ac]Ac-PSMA radioligand therapy.

Saved in:
Bibliographic Details
Title: PET-based risk stratification for adverse events under [225Ac]Ac-PSMA radioligand therapy.
Authors: Widjaja L; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany. Liam.Widjaja@med.uni-muenchen.de.; Bavarian Cancer Research Center (BZKF), partner site Munich, Munich, Germany. Liam.Widjaja@med.uni-muenchen.de., Siegmund SC; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany.; Bavarian Cancer Research Center (BZKF), partner site Munich, Munich, Germany., Gildehaus FJ; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany., Schmidt-Hegemann NS; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany., Pomper MG; Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Rowe SP; Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Bundschuh RA; Department of Nuclear Medicine, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.; Institute of Radiopharmaceutical Cancer Research, Helmholtz Zentrum Dresden- Rossendorf (HZDR), Rossendorf, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany.; Faculty of Medicine, National Center for Tumor Diseases (NCT), NCT/UCC Dresden, University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany., Wenter V; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany., Sheikh GT; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany., Klimek K; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany., Stief CG; Department of Urology, LMU University Hospital, LMU Munich, Munich, Germany., Zacherl MJ; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany., Werner RA; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, a partnership between DKFZ and LMU University Hospital Munich, Munich, Germany., Casuscelli J; Department of Urology, LMU University Hospital, LMU Munich, Munich, Germany.
Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2026 Jun; Vol. 53 (7), pp. 4360-4373. Date of Electronic Publication: 2026 Feb 09.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41656419
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: PET-based risk stratification for adverse events under [<superscript>225</superscript>Ac]Ac-PSMA radioligand therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Widjaja+L%22">Widjaja L</searchLink>; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany. Liam.Widjaja@med.uni-muenchen.de.; Bavarian Cancer Research Center (BZKF), partner site Munich, Munich, Germany. Liam.Widjaja@med.uni-muenchen.de.<br /><searchLink fieldCode="AU" term="%22Siegmund+SC%22">Siegmund SC</searchLink>; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany.; Bavarian Cancer Research Center (BZKF), partner site Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Gildehaus+FJ%22">Gildehaus FJ</searchLink>; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Schmidt-Hegemann+NS%22">Schmidt-Hegemann NS</searchLink>; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Pomper+MG%22">Pomper MG</searchLink>; Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Rowe+SP%22">Rowe SP</searchLink>; Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Bundschuh+RA%22">Bundschuh RA</searchLink>; Department of Nuclear Medicine, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.; Institute of Radiopharmaceutical Cancer Research, Helmholtz Zentrum Dresden- Rossendorf (HZDR), Rossendorf, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany.; Faculty of Medicine, National Center for Tumor Diseases (NCT), NCT/UCC Dresden, University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Wenter+V%22">Wenter V</searchLink>; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Sheikh+GT%22">Sheikh GT</searchLink>; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Klimek+K%22">Klimek K</searchLink>; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Stief+CG%22">Stief CG</searchLink>; Department of Urology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Zacherl+MJ%22">Zacherl MJ</searchLink>; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Werner+RA%22">Werner RA</searchLink>; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15 , D-81377, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, a partnership between DKFZ and LMU University Hospital Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Casuscelli+J%22">Casuscelli J</searchLink>; Department of Urology, LMU University Hospital, LMU Munich, Munich, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101140988%22">European journal of nuclear medicine and molecular imaging</searchLink> [Eur J Nucl Med Mol Imaging] 2026 Jun; Vol. 53 (7), pp. 4360-4373. <i>Date of Electronic Publication: </i>2026 Feb 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+Berlin%22">Springer-Verlag Berlin </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101140988 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1619-7089 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216197070%22">16197070 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Nucl Med Mol Imaging <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41656419
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00259-026-07788-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4360
    Titles:
      – TitleFull: PET-based risk stratification for adverse events under [225Ac]Ac-PSMA radioligand therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Widjaja L
      – PersonEntity:
          Name:
            NameFull: Siegmund SC
      – PersonEntity:
          Name:
            NameFull: Gildehaus FJ
      – PersonEntity:
          Name:
            NameFull: Schmidt-Hegemann NS
      – PersonEntity:
          Name:
            NameFull: Pomper MG
      – PersonEntity:
          Name:
            NameFull: Rowe SP
      – PersonEntity:
          Name:
            NameFull: Bundschuh RA
      – PersonEntity:
          Name:
            NameFull: Wenter V
      – PersonEntity:
          Name:
            NameFull: Sheikh GT
      – PersonEntity:
          Name:
            NameFull: Klimek K
      – PersonEntity:
          Name:
            NameFull: Stief CG
      – PersonEntity:
          Name:
            NameFull: Zacherl MJ
      – PersonEntity:
          Name:
            NameFull: Werner RA
      – PersonEntity:
          Name:
            NameFull: Casuscelli J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1619-7089
          Numbering:
            – Type: volume
              Value: 53
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: European journal of nuclear medicine and molecular imaging
              Type: main
ResultId 1